Trial of Enasidenib Maintenance Post Allogeneic Hematopoietic Cell Transplant in Patients With IDH-2 Mutated AML. uri icon

authors

  • Salhotra, Amandeep
  • Aldoss, Ibrahim
  • Andrew Artz, MD, MS
  • Aribi, Ahmed
  • Elmariah, Hany
  • Sahebi, Firoozeh
  • Mansour, Joshua
  • Ball, Brian J
  • Agrawal, Vaibhav
  • Li, Ling
  • Pullarkat, Vinod A
  • Bejanyan, Nelli
  • Forman, Stephen J
  • Marcucci, Guido
  • Stein, Anthony S
  • Nakamura, Ryotaro
  • Yang, Dongyun
  • Mokhtari, Sally
  • Knobler, Diana
  • Park, Gabriel
  • Malki, Monzr M Al
  • Sandhu, Karamjeet S
  • Faramand, Rawan

publication date

  • September 19, 2025